This contract expires in 259 days (Dec 31, 2026).
FIRM FIXED PRICENO SET ASIDE USED.
EXELAN PHARMACEUTICALS INC - LENALIDOMIDE/REVLIMID DOSE
PIID: 36C25226P0109Solicitation ID: 36C25226Q0109
Signed Date: Dec 11, 2025Effective Date: Dec 15, 2025End Date: Closes in 259 days
Key Details
Description
LENALIDOMIDE/REVLIMID DOSE
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.